BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17440072)

  • 1. Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor.
    Bradley SV; Holland EC; Liu GY; Thomas D; Hyun TS; Ross TS
    Cancer Res; 2007 Apr; 67(8):3609-15. PubMed ID: 17440072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant Huntingtin interacting protein 1 in lymphoid malignancies.
    Bradley SV; Smith MR; Hyun TS; Lucas PC; Li L; Antonuk D; Joshi I; Jin F; Ross TS
    Cancer Res; 2007 Sep; 67(18):8923-31. PubMed ID: 17875735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antibodies to huntingtin interacting protein-1: a new blood test for prostate cancer.
    Bradley SV; Oravecz-Wilson KI; Bougeard G; Mizukami I; Li L; Munaco AJ; Sreekumar A; Corradetti MN; Chinnaiyan AM; Sanda MG; Ross TS
    Cancer Res; 2005 May; 65(10):4126-33. PubMed ID: 15899803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival.
    Rao DS; Hyun TS; Kumar PD; Mizukami IF; Rubin MA; Lucas PC; Sanda MG; Ross TS
    J Clin Invest; 2002 Aug; 110(3):351-60. PubMed ID: 12163454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenascin C and epidermal growth factor receptor as markers of circulating tumoral cells in bladder and colon cancer.
    Gazzaniga P; Nofroni I; Gandini O; Silvestri I; Frati L; Aglianò AM; Gradilone A
    Oncol Rep; 2005 Nov; 14(5):1199-202. PubMed ID: 16211285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIP1: trafficking roles and regulation of tumorigenesis.
    Hyun TS; Ross TS
    Trends Mol Med; 2004 Apr; 10(4):194-9. PubMed ID: 15059611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers.
    Toyama T; Yamashita H; Kondo N; Okuda K; Takahashi S; Sasaki H; Sugiura H; Iwase H; Fujii Y
    BMC Cancer; 2008 Oct; 8():309. PubMed ID: 18950515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.
    Schlomm T; Kirstein P; Iwers L; Daniel B; Steuber T; Walz J; Chun FH; Haese A; Kollermann J; Graefen M; Huland H; Sauter G; Simon R; Erbersdobler A
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6579-84. PubMed ID: 18006757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients.
    Lieto E; Ferraraccio F; Orditura M; Castellano P; Mura AL; Pinto M; Zamboli A; De Vita F; Galizia G
    Ann Surg Oncol; 2008 Jan; 15(1):69-79. PubMed ID: 17896140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huntingtin interacting protein 1 Is a clathrin coat binding protein required for differentiation of late spermatogenic progenitors.
    Rao DS; Chang JC; Kumar PD; Mizukami I; Smithson GM; Bradley SV; Parlow AF; Ross TS
    Mol Cell Biol; 2001 Nov; 21(22):7796-806. PubMed ID: 11604514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas.
    Xu K; Shu HK
    Cancer Res; 2007 Jul; 67(13):6121-9. PubMed ID: 17616668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor promotes epidermal growth factor receptor nuclear accumulation by a pathway dependent on cytoskeleton integrity in human breast cancer cells.
    Cortes-Reynosa P; Robledo T; Salazar EP
    Arch Med Res; 2009 Jul; 40(5):331-8. PubMed ID: 19766894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer.
    Dihge L; Bendahl PO; Grabau D; Isola J; Lövgren K; Rydén L; Fernö M
    Breast Cancer Res Treat; 2008 May; 109(2):255-62. PubMed ID: 17636398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.
    Fei J; Hong A; Dobbins TA; Jones D; Lee CS; Loo C; Al-Ghamdi M; Harnett GB; Clark J; O'Brien CJ; Rose B
    Ann Surg Oncol; 2009 Oct; 16(10):2908-17. PubMed ID: 19603236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer.
    Arnes JB; Bégin LR; Stefansson I; Brunet JS; Nielsen TO; Foulkes WD; Akslen LA
    J Clin Pathol; 2009 Feb; 62(2):139-46. PubMed ID: 18682421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation.
    Sigismund S; Argenzio E; Tosoni D; Cavallaro E; Polo S; Di Fiore PP
    Dev Cell; 2008 Aug; 15(2):209-19. PubMed ID: 18694561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma.
    Foster JM; Gatalica Z; Lilleberg S; Haynatzki G; Loggie BW
    Ann Surg Oncol; 2009 Jan; 16(1):152-8. PubMed ID: 18998063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huntingtin Interacting Protein 1 mutations lead to abnormal hematopoiesis, spinal defects and cataracts.
    Oravecz-Wilson KI; Kiel MJ; Li L; Rao DS; Saint-Dic D; Kumar PD; Provot MM; Hankenson KD; Reddy VN; Lieberman AP; Morrison SJ; Ross TS
    Hum Mol Genet; 2004 Apr; 13(8):851-67. PubMed ID: 14998932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components.
    Sarkaria IS; Zakowski MF; Pham D; Hezel M; Ebright MI; Chuai S; Venkatraman ES; Kris MG; Rusch VW; Singh B
    Ann Thorac Surg; 2008 Jan; 85(1):216-23. PubMed ID: 18154814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.